Adela Valero M, Victoria Periago M, Pérez-Crespo I, Rodríguez E, Jesús Perteguer M, Gárate T, Mas-Coma S (2012) Assessing the validity of an ELISA test for the serological diagnosis of human fascioliasis in different epidemiological situations. Trop Med Int Health 17(5):630–636. https://doi.org/10.1111/j.1365-3156.2012.02964.x ArticleCASPubMed Google Scholar
Chen M, Mott K (1990) Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 87(4):1–38 Google Scholar
Cornelissen JB, Gaasenbeek CP, Borgsteede FH, Holland WG, Harmsen MM, Boersma WJ (2001) Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease. Int J Parasitol 31(7):728–737. https://doi.org/10.1016/s0020-7519(01)00175-8 ArticleCASPubMed Google Scholar
Dalton JP, Neill SO, Stack C, Collins P, Walshe A, Sekiya M, Khaznadji E (2003) Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. Int J Parasitol 33(11):1173–1181. https://doi.org/10.1016/s0020-7519(03)00057-2 ArticleCASPubMed Google Scholar
Demerdash ZA, Diab TM, Aly IR, Mohamed SH, Mahmoud FS, Zoheiry MK, El-Bassiouny AE (2011) Diagnostic efficacy of monoclonal antibody based sandwich enzyme linked immunosorbent assay (ELISA) for detection of Fasciola gigantica excretory/secretory antigens in both serum and stool. Parasites Vectors 4(1):176. https://doi.org/10.1186/1756-3305-4-176 ArticleCASPubMedPubMed Central Google Scholar
Espino AM, Morales A, Delgado B, Rivera FM, Figueroa O, Suárez E (2010) Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct. Ethnicity Dis 20(101):S1 Google Scholar
Gironènes N, Valero MA, García-Bodelón MA, Chico-Calero I, Punzón C, Presno M, Mas-Coma S (2007) Immune suppression in advanced chronic fascioliasis: an experimental study in a rat model. J Infect Dis 195(10):1504–1512. https://doi.org/10.1086/514822 ArticleCAS Google Scholar
Gottstein B, Schneeberger M, Boubaker G, Merkle B, Huber C, Spiliotis M, Doherr MG (2014) Comparative assessment of ELISAs using recombinant saposin-like protein 2 and recombinant cathepsin L-1 from Fasciola hepatica for the serodiagnosis of human fasciolosis. PLoS Negl Trop Dis 8(6):e2860. https://doi.org/10.1371/journal.pntd.0002860 ArticleCASPubMedPubMed Central Google Scholar
Hillyer GV (1999) Immunodiagnosis of human and animal fasciolosis. Fasciolosis 13:435–447 Google Scholar
Hillyer GV, de Galanes MS, Rodriguez-Perez J, Bjorland J, de Lagrava MS, Guzman SR, Bryan RT (1992) Use of the FalconTM assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian altiplano. Am J Trop Med Hyg 46(5):603–609. https://doi.org/10.4269/ajtmh.1992.46.603 ArticleCASPubMed Google Scholar
Itoh M, Sato S (1990) Multi-dot enzyme-linked immunosorbent assay for serodiagnosis of trematodiasis. Southeast Asian J Trop Med Public Health 21(3):471–474 CASPubMed Google Scholar
Kuerpick B, Schnieder T, Strube C (2013) Evaluation of a recombinant cathepsin L1 ELISA and comparison with the Pourquier and ES ELISA for the detection of antibodies against Fasciola hepatica. Vet Parasitol 193(1–3):206–213. https://doi.org/10.1016/j.vetpar.2012.11.021 ArticleCASPubMed Google Scholar
Law RH, Smooker PM, Irving JA, Piedrafita D, Ponting R, Kennedy NJ, Spithill TW (2003) Cloning and expression of the major secreted cathepsin B-like protein from juvenile Fasciola hepatica and analysis of immunogenicity following liver fluke infection. Infect Immun 71(12):6921–6932. https://doi.org/10.1128/IAI.71.12.6921-6932.2003 ArticleCASPubMedPubMed Central Google Scholar
Lobstein J, Emrich CA, Jeans C, Faulkner M, Riggs P, Berkmen M (2012) SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm. Microb Cell Fact 11(1):753. https://doi.org/10.1186/1475-2859-11-56 ArticleCAS Google Scholar
Maleewong W, Intapan P, Wongkham C, Tomanakan K, Daenseekaew W, Sukeepaisarnjaroen W (1996) Comparison of adult somatic and excretory-secretory antigens in enzyme-linked immunosorbent assay for serodiagnosis of human infection with Fasciola gigantica. Southeast Asian J Trop Med Public Health 27(3):566–569 CASPubMed Google Scholar
Marcilla A, De la Rubia J, Sotillo J, Bernal D, Carmona C, Villavicencio Z, Esteban J (2008) Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections. Clin Vaccine Immunol 15(1):95–100. https://doi.org/10.1128/CVI.00338-07 ArticleCASPubMed Google Scholar
Mas-Coma M, Esteban J, Bargues M (1999) Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77(4):340 CASPubMedPubMed Central Google Scholar
Mas-Coma S, Valero MA, Bargues MD (2009) Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol 69:41–146. https://doi.org/10.1016/S0065-308X(09)69002-3 ArticlePubMed Google Scholar
Mas CS, Bargues M (1997) Human liver flukes: a review. Res Rev Parasitol 57:15–218 Google Scholar
Mezo M, González-Warleta M, Carro C, Ubeira FM (2004) An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3). J Parasitol 90(4):845–852. https://doi.org/10.1645/GE-192R ArticlePubMed Google Scholar
Mirzadeh A, Saadatnia G, Golkar M, Babaie J, Noordin R (2017) Production of refolded Toxoplasma gondii recombinant SAG1-related sequence 3 (SRS3) and its use for serodiagnosis of human toxoplasmosis. Protein Expr Purif 133:66–74. https://doi.org/10.1016/j.pep.2017.03.001 ArticleCASPubMed Google Scholar
Mirzadeh A, Valadkhani Z, Yoosefy A, Babaie J, Golkar M, Rastaghi ARE, Ashrafi K (2017) Expression, purification and in vitro refolding of the recombinant truncated Saposin-like protein 2 antigen for development of diagnosis of human fascioliasis. Acta Trop 171:163–171. https://doi.org/10.1016/j.actatropica.2017.03.002 ArticleCASPubMed Google Scholar
Mokhtarian K, Akhlaghi L, Meamar AR, Razmjou E, Naeini KM, Gholami S, Falak R (2016) Serodiagnosis of fasciolosis by fast protein liquid chromatography-fractionated excretory/secretory antigens. Parasitol Res 115(8):2957–2965. https://doi.org/10.1007/s00436-016-5049-7 ArticlePubMed Google Scholar
Mokhtarian K, Akhlaghi L, Mohammadi M, Meamar AR, Razmjou E, Khoshmirsafa M, Falak R (2016) Evaluation of anti-Cathepsin L1: a more reliable method for serodiagnosis of human fasciolosis. Trans R Soc Trop Med Hyg 110(9):542–550. https://doi.org/10.1093/trstmh/trw063 ArticleCASPubMed Google Scholar
O’Neill SM, Parkinson M, Strauss W, Angles R, Dalton JP (1998) Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am J Trop Med Hyg 58(4):417–423. https://doi.org/10.4269/ajtmh.1998.58.417 ArticleCASPubMed Google Scholar
World Health Organization (2005) The selection and use of essential medicines: report of the WHO expert committee, 2005 (including the 14th model list of essential medicines). World Health Organization, Geneva (ISBN: 9789241209502) Google Scholar
Sabry H, Mohamed S (2007) Diagnosis efficacy of anti-cysteine protease for detection of Fasciola antigen in serum and stool samples. New Egypt J Med 36:163–169 Google Scholar
Salimi-Bejestani M, McGarry J, Felstead S, Ortiz P, Akca A, Williams DJ (2005) Development of an antibody-detection ELISA for Fasciola hepatica and its evaluation against a commercially available test. Res Vet Sci 78(2):177–181. https://doi.org/10.1016/j.rvsc.2004.08.005 ArticleCASPubMed Google Scholar
Santana BG, Dalton JP, Camargo FV, Parkinson M, Ndao M (2013) The diagnosis of human fascioliasis by enzyme-linked immunosorbent assay (ELISA) using recombinant cathepsin L protease. PLoS Negl Trop Dis 7(9):e2414. https://doi.org/10.1371/journal.pntd.0002414 Article Google Scholar
Scott JC, Kennedy MW, McManus DP (2000) Molecular and immunological characterisation of a polymorphic cytosolic fatty acid binding protein from the human blood fluke of humans, Schistosoma japonicum 1. Biochim Biophys Acta 1517(1):53–62. https://doi.org/10.1016/S0167-4781(00)00254-2 ArticleCASPubMed Google Scholar
Shaheen HI, Kamal KA, Farid Z, Mansour N, Boctor FN, Woody JN (1989) Dot-enzyme-linked immunosorbent assay (dot-ELISA) for the rapid diagnosis of human fascioliasis. J Parasitol 75:549–552. https://doi.org/10.2307/3282904 ArticleCASPubMed Google Scholar
Sobhorn P, Anantavara S, Dangprasert T, Viyanant V, Krailas D, Upatham E, Kusamran T (1998) Fasciola gigantica: studies of the tegument as a basis for the developments of immunodiagnosis and vaccine. Southeast Asian J Trop Med Public Health 29:387–400 Google Scholar
Spithill TW, Smooker PM, Bruce D (1999) 15 Fasciola gigantica: epidemiology, control, immunology and molecular biology. Fasciolosis 50(2):465–525 Google Scholar
Tantrawatpan C, Maleewong W, Wongkham C, Wongkham S, Intapan P, Nakashima K (2007) Evaluation of immunoglobulin G4 subclass antibody in a peptide-based enzyme-linked immunosorbent assay for the serodiagnosis of human fascioliasis. Parasitology 134(14):2021–2026. https://doi.org/10.1017/S0031182007003435 ArticleCASPubMed Google Scholar
Tantrawatpan C, Maleewong W, Wongkham C, Wongkham S, Intapan PM, Nakashima K (2005) Serodiagnosis of human fascioliasis by a cystatin capture enzyme-linked immunosorbent assay with recombinant Fasciola gigantica cathepsin L antigen. Am J Trop Med Hyg 72(1):82–86. https://doi.org/10.4269/ajtmh.2005.72.82 ArticleCASPubMed Google Scholar
Teofanova D, Hristov P, Yoveva A, Radoslavov G (2012) Native and recombinant fatty acid binding protein 3 from Fasciola hepatica as a potential antigen. Biotechnol Biotechnol Equip 26(sup1):60–64. https://doi.org/10.5504/50YRTIMB.2011.0011 Article Google Scholar
Timanova-Atanasova A, Jordanova R, Radoslavov G, Deevska G, Bankov I, Barrett J (2004) A native 13-kDa fatty acid binding protein from the liver fluke Fasciola hepatica. Biochimica Biophys Acta (BBA) 1674(2):200–204. https://doi.org/10.1016/j.bbagen.2004.06.018 ArticleCAS Google Scholar
Torres D, Espino AM (2006) Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica_–_Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family. Infect Immun 74(8):4932–4938. https://doi.org/10.1128/IAI.00442-06 ArticleCASPubMedPubMed Central Google Scholar
Ubeira FM, Muiño L, Valero MA, Periago MV, Pérez-Crespo I, Mezo M, Cortizo S (2009) MM3-ELISA detection of Fasciola hepatica coproantigens in preserved human stool samples. Am J Trop Med Hyg 81(1):156–162. https://doi.org/10.4269/ajtmh.2009.81.156 ArticlePubMed Google Scholar
Wongkham C, Tantrawatpan C, Intapan PM, Maleewong W, Wongkham S, Nakashima K (2005) Evaluation of immunoglobulin G subclass antibodies against recombinant Fasciola gigantica cathepsin L1 in an enzyme-linked immunosorbent assay for serodiagnosis of human fasciolosis. Clin Diagn Lab Immunol 12(10):1152–1156. https://doi.org/10.1128/CDLI.12.10.1152-1156.2005 ArticleCASPubMedPubMed Central Google Scholar
Yoosefy A, Mirzadeh A, Babaie J, Golkar M, Valadkhani Z (2018) High-level expression of recombinant saposin-Like protein-2 of Fasciola hepatica and its single step purification. J Chem Pharmaceut Res 10(4):29–34 CAS Google Scholar